PPARA and metabolic dysfunction-associated steatotic liver disease: FABP1 is downstream of the PPAR signaling pathway, and the silencing of FABP1 in the liver ameliorated hepatic oxidative stress and inflammation in a mouse model of nonalcoholic fatty liver disease [51].